Shamik J. Parikh - 16 Nov 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Chief Medical Officer
Signature
/s/ Shamik J. Parikh by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
16 Nov 2025
Net transactions value
$0
Form type
4
Filing time
17 Nov 2025, 17:51:24 UTC
Previous filing
14 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Parikh Shamik J Chief Medical Officer 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM /s/ Shamik J. Parikh by Dale A. Sander as Attorney-in-Fact 17 Nov 2025 0001916853

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Award $0 +311,100 +4148% $0.000000 318,600 16 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027.